Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,862 | 39,880 | 3,696 | 5,997 | 13,410 |
| Marketable Securities | 11,931 | 3,564 | 1,345 | 133 | 2,957 |
| Receivables | 4,677 | 7,565 | 29 | N/A | N/A |
| Inventories | 684 | 497 | 349 | N/A | N/A |
| TOTAL | $45,445 | $53,397 | $6,442 | $7,501 | $16,848 |
| Non-Current Assets | |||||
| PPE Net | 633 | 511 | 280 | 127 | 38 |
| Investments And Advances | 737 | 689 | 244 | 244 | 178 |
| Intangibles | 97,156 | 98,970 | 85,520 | 12,586 | 2,051 |
| Other Non-Current Assets | 1,961 | 1,968 | 1,562 | 40 | 2,250 |
| TOTAL | $100,487 | $102,138 | $87,606 | $12,998 | $4,517 |
| Total Assets | $145,932 | $155,535 | $94,049 | $20,499 | $21,365 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,285 | 10,625 | 5,711 | 3,554 | 3,423 |
| Accrued Expenses | 11,692 | 7,234 | 3,302 | 4,881 | 3,667 |
| Other current liabilities | 26,158 | 30,126 | 73,151 | 28,130 | 23,853 |
| TOTAL | $49,135 | $47,985 | $113,447 | $36,565 | $30,943 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,160 | 39,835 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 66,684 | 66,508 | 13,327 | 1,000 | 0 |
| TOTAL | $106,985 | $106,484 | $15,994 | $3,601 | $N/A |
| Total Liabilities | $156,120 | $154,469 | $129,441 | $40,166 | $30,943 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,700 | 26,682 | 25,485 | 35,073 | 35,073 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -149,135 | -129,578 | -138,061 | -68,237 | -55,645 |
| Other shareholders' equity | 3,530 | 194 | 297 | -67 | -155 |
| TOTAL | $-10,188 | $1,067 | $-35,392 | $-19,667 | $-9,578 |
| Total Liabilities And Equity | $145,932 | $155,535 | $94,049 | $20,499 | $21,365 |